San Diego-based Viking Therapeutics marked itself as a serious competitor inside the weight loss drug sector in February right after revealing promising information from the mid-phase trial of experimental drug VK2735, which instructed it rivaled—and outperformed—Novo and Lilly drugs when offered as being a weekly injection and in March the com